Capgemini SE header image

Capgemini SE

CAP

Equity

ISIN FR0000125338 / Valor 488070

Euronext - Euronext Paris (2026-11-02)
EUR 127.25+3.70%

Capgemini SE
UMushroom community rating:

star star star star star
5.00 1 votes No rating yet
NegativeNeutralPositive

About company

Capgemini SE, with over five decades of experience, stands as a pivotal force in the global consulting and technology services sector. The company distinguishes itself by offering a comprehensive suite of services that cater to a wide array of business needs, encompassing strategy formulation, design, and operational management. At the heart of Capgemini's value proposition is its profound industry knowledge coupled with an adeptness in navigating rapidly advancing technological domains such as cloud computing, data analytics, artificial intelligence, connectivity, software development, digital engineering, and platform services. This blend of strategic insight and technological prowess enables Capgemini to serve as a strategic partner to businesses worldwide, facilitating their transformational journeys in an increasingly digital landscape.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-2.18%1Y
-21.1%3Y
-36.6%5Y

Performance

40.1%1Y
32.1%3Y
31.5%5Y

Volatility

Market cap

24283 M

Market cap (USD)

Daily traded volume (Shares)

775,587

Daily traded volume (Shares)

1 day high/low

157.45 / 154.75

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

5.00

1 votes
Performance:
starstarstarstarstar
5.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
5.00
Raphaël Domergue
Switzerland, 02 Oct 2026
star star star star star
Capgemini offers exposure to consulting, technology services and digital transformation. I see potential in its expertise in cloud, data and AI. My investment view would depend on client spending, contract growth and sustainable profitability.

EQUITIES OF THE SAME SECTOR

Repligen Corp
Repligen Corp Repligen Corp Valor: 965900
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.20%USD 176.94
CoreWeave, Inc. Class A
CoreWeave, Inc. Class A CoreWeave, Inc. Class A Valor: 142894318
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.66%USD 54.87
Syrma SGS Technology Limited
Syrma SGS Technology Limited Syrma SGS Technology Limited Valor: 120969771
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.85%INR 1,620.90
TBO Tek Ltd.
TBO Tek Ltd. TBO Tek Ltd. Valor: 115751114
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.81%INR 1,536.90
Allgeier SE
Allgeier SE Allgeier SE Valor: 38363747
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.58%EUR 13.90
DATA MODUL Aktiengesellschaft Produktion und Vertrieb von elektronischen Systemen
DATA MODUL Aktiengesellschaft Produktion und Vertrieb von elektronischen Systemen DATA MODUL Aktiengesellschaft Produktion und Vertrieb von elektronischen Systemen Valor: 328137
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 25.60
B+S Banksysteme Aktiengesellschaft
B+S Banksysteme Aktiengesellschaft B+S Banksysteme Aktiengesellschaft Valor: 1702263
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 1.80
Evolution AB
Evolution AB Evolution AB Valor: 48025470
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.39%SEK 824.20
Addnode Group AB
Addnode Group AB Addnode Group AB Valor: 119004945
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%SEK 65.90
Biomarin Pharmaceutical Inc
Biomarin Pharmaceutical Inc Biomarin Pharmaceutical Inc Valor: 729021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.77%USD 58.51